• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biological Resources Institute (Japan) signs an MOU to develop a bird flu vaccine for Indonesia

Laidback Al

Well-known member
Computer translated

Bird flu vaccine verification Ken biological resources, in Indonesia

Aug 15, 2012 Posted Date

Biological Resources Institute (Nago, Okinawa Prefecture, president Kuniaki Nerome, 0980.54.3376) is 14, has signed a memorandum of understanding on the development of vaccine against bird flu, Indonesia and Bogor Agricultural University. Outdoors in Indonesia to verify virus is endemic, an antiseptic and anti-bird flu vaccine laboratory are developing biological resources.
 Biological Resources Institute, been adopted in the "business of Research and Development New Industry Creation" Okinawa in Okinawa Prefecture, has been promoting research and discovery of emerging viral infections in Southeast Asia, the development of viral vaccines and disinfectant. As a result, using the new genetic technology, has established a technology for production of vaccine proteins.  
In particular it is often cut the virulence genes of 21, succeeded in the synthesis of viral DNA of H5 influenza virus type A. Gene by binding the virus that is not natural to this DNA, were synthesized DNA for vaccine production hybrid due to the binding of cell-derived genes and viral genes.
http://www.nikkan.co.jp/news/nkx1020120815aaav.html

More behind a pay wall.
 
Back
Top